$18.42
-0.2-1.07%
At close: -
$18.42
0.00180.01%
After Hours: 7:35 PM EDT
Comments
Loading...
Latest news for Summit Therapeutics (NASDAQ:SMMT) Stock
Summit Therapeutics Stock (NASDAQ: SMMT)
Categories: All
Monday, November 18, 2024
Saturday, November 09, 2024
Monday, November 04, 2024
- Summit Therapeutics 'Unique Investment In Oncology,' Lead Drug Candidate Shows Promise Over Keytruda And Opdivo
- Summit Therapeutics shares are trading higher...
- This Tencent Music Entertainment Analyst Begins Coverage On A Bullish Note; Here Are Top 5 Initiations For Monday
- JMP Securities Initiates Coverage On Summit T...
Thursday, October 31, 2024
Wednesday, October 30, 2024
Tuesday, October 29, 2024
Thursday, October 24, 2024
Wednesday, October 16, 2024
Thursday, October 10, 2024
Sunday, October 06, 2024
Friday, October 04, 2024
Thursday, October 03, 2024
Wednesday, October 02, 2024
Sunday, September 29, 2024
Friday, September 27, 2024
Wednesday, September 25, 2024
Sunday, September 22, 2024
Wednesday, September 18, 2024
Tuesday, September 17, 2024
Monday, September 16, 2024
Sunday, September 15, 2024
Friday, September 13, 2024
Thursday, September 12, 2024
Wednesday, September 11, 2024
Tuesday, September 10, 2024
Monday, September 09, 2024
- Citigroup Maintains Buy on Summit Therapeutic...
- Terns Pharmaceuticals, Boeing, Tesla And Other Big Stocks Moving Higher On Monday
- Stifel Maintains Buy on Summit Therapeutics, ...
- Summit Therapeutics shares are trading higher...
- Starbucks To Rally Around 21%? Here Are 10 Top Analyst Forecasts For Monday
- Market-Moving News for September 9th
- Summit Therapeutics' Lung Cancer Candidate Surpasses Merck's Multi-Billion Dollar Keytruda, Cuts Risk Of Disease Or Death By Half
- Summit Theraperutics shares are trading highe...
- HC Wainwright & Co. Maintains Buy on Summit T...
- Why Summit Therapeutics Shares Are Trading Higher By Around 18%; Here Are 20 Stocks Moving Premarket